Seo S, Choi J, Jung D, Park Y, Yang E, Jung S
Virol J. 2024; 21(1):220.
PMID: 39285440
PMC: 11406814.
DOI: 10.1186/s12985-024-02491-y.
Guo J, Zhang Y, Zhang Y, Zhang C, Zhu C, Xing M
Emerg Microbes Infect. 2021; 10(1):1947-1959.
PMID: 34520320
PMC: 8477930.
DOI: 10.1080/22221751.2021.1981157.
Coles C, Millar E, Burgess T, Ottolini M
Mil Med. 2019; 184(Suppl 2):44-50.
PMID: 31778194
PMC: 6886571.
DOI: 10.1093/milmed/usz174.
Kutter J, Spronken M, Fraaij P, Fouchier R, Herfst S
Curr Opin Virol. 2018; 28:142-151.
PMID: 29452994
PMC: 7102683.
DOI: 10.1016/j.coviro.2018.01.001.
Yun H, Young A, Caballero M, Lott L, Cropper T, Murray C
Open Forum Infect Dis. 2015; 2(3):ofv120.
PMID: 26380351
PMC: 4569648.
DOI: 10.1093/ofid/ofv120.
Retrospective analysis of demographic and clinical factors associated with etiology of febrile respiratory illness among US military basic trainees.
Padin D, Faix D, Brodine S, Lemus H, Hawksworth A, Putnam S
BMC Infect Dis. 2014; 14:576.
PMID: 25475044
PMC: 4264259.
DOI: 10.1186/s12879-014-0576-2.
Acute lower respiratory tract infections in soldiers, South Korea, April 2011-March 2012.
Heo J, Lee J, Kim H, Choe K
Emerg Infect Dis. 2014; 20(5):875-7.
PMID: 24750820
PMC: 4012816.
DOI: 10.3201/eid2005.131692.
Update on viral community-acquired pneumonia.
Rocha Neto O, Leite R, Baldi B
Rev Assoc Med Bras (1992). 2013; 59(1):78-84.
PMID: 23440146
PMC: 7133596.
Immunogenicity when utilizing adenovirus serotype 4 and 5 vaccines expressing circumsporozoite protein in naïve and adenovirus (Ad5) immune mice.
Schuldt N, Aldhamen Y, Godbehere-Roosa S, Seregin S, Kousa Y, Amalfitano A
Malar J. 2012; 11:209.
PMID: 22720732
PMC: 3472263.
DOI: 10.1186/1475-2875-11-209.
Pneumonia in military trainees: a comparison study based on adenovirus serotype 14 infection.
Vento T, Prakash V, Murray C, Brosch L, Tchandja J, Cogburn C
J Infect Dis. 2011; 203(10):1388-95.
PMID: 21502080
PMC: 3080896.
DOI: 10.1093/infdis/jir040.
Replication-attenuated Human Adenoviral Type 4 vectors elicit capsid dependent enhanced innate immune responses that are partially dependent upon interactions with the complement system.
Hartman Z, Appledorn D, Serra D, Glass O, Mendelson T, Clay T
Virology. 2008; 374(2):453-67.
PMID: 18280530
PMC: 2720025.
DOI: 10.1016/j.virol.2008.01.017.
Transmission dynamics and prospective environmental sampling of adenovirus in a military recruit setting.
Russell K, Broderick M, Franklin S, Blyn L, Freed N, Moradi E
J Infect Dis. 2006; 194(7):877-85.
PMID: 16960774
PMC: 7109706.
DOI: 10.1086/507426.
Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004.
Russell K, Hawksworth A, Ryan M, Strickler J, Irvine M, Hansen C
Vaccine. 2006; 24(15):2835-42.
PMID: 16480793
PMC: 1955759.
DOI: 10.1016/j.vaccine.2005.12.062.
Efficacy of and indications for use of adenovirus vaccine.
HILLEMAN M
Am J Public Health Nations Health. 1958; 48(2):153-8.
PMID: 13521062
PMC: 1551483.
DOI: 10.2105/ajph.48.2.153.
Respiratory viruses. Current status and future prospects.
Rifkind D
Calif Med. 1965; 103(6):387-94.
PMID: 5847735
PMC: 1516032.
Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy.
van der Veen J, Abarbanel M, OEI K
J Hyg (Lond). 1968; 66(4):499-511.
PMID: 4303951
PMC: 2130674.
DOI: 10.1017/s0022172400028242.
Reference equine antisera to 33 human adenovirus types: homologous and heterologous titers.
Hierholzer J, Gamble W, Dowdle W
J Clin Microbiol. 1975; 1(1):65-74.
PMID: 1236869
PMC: 274943.
DOI: 10.1128/jcm.1.1.65-74.1975.
Control of adenovirus acute respiratory disease in U.S. Army trainees.
Top Jr F
Yale J Biol Med. 1975; 48(3):185-95.
PMID: 1099823
PMC: 2595226.
Introduction acute respiratory infections in military personnel.
Evans A
Yale J Biol Med. 1975; 48(3):167-9.
PMID: 808910
PMC: 2595235.
